July College News

July 31, 2021

  • The number of family medicine residents with more than $250,000 in self-reported educational debt increased by 81% over a five-year period, according to a study led by Julie Phillips, MD, professor in the Department of Family Medicine.
  • new rare genetic syndrome went from a collection of symptoms to a successful treatment in less than two years with the help of three professors in the Department of Pediatrics and Human Development, André S. Bachmann, PhD, Caleb Bupp, MD, and Surender Rajasekaran, MDRelated Media: FOX 17Medical XpressMicrosoft NewsNews MedicalThe Today Show
  • Morteza Mahmoudi, PhD, assistant professor in the Precision Health Program, is leading an international team of scientists to develop a low-cost, practical biopolymer dressing that helps heal chronic wounds. Related Media: Medical XpressNews MedicalScienceDaily.
  • Disparities in colorectal cancer screening in African Americans result in a higher death rate among that segment of the population. Todd Lucas, PhD, C.S. Mott Endowed Professor of Public Health, and his research team will use a five-year, $1.7 million Research Scholar Grant from the American Cancer Society to study colorectal cancer screening and health equity.
  • Alyssa Vanderziel, MS, a PhD candidate in the Department of Epidemiology & Biostatistics and graduate research assistant in the Department of Family Medicine, was awarded an R36 from the National Institute on Drug Abuse of the National Institutes of Health. The R36 award will support Vanderziel’s research project “Cannabis Legalization and Use During Pregnancy: A Michigan Study.”
  • College of Human Medicine student Heather Martin completed a research project with Spectrum Health stroke neurologist Muhib Khan, MD, evaluating the impact of anticoagulation initiation in patients with stroke due to atrial fibrillation. Five manuscripts have been published in high impact journal such as Journal of Neurology, Neurosurgery and Psychiatry; Stroke and Annals of Neurology.
  • In an op-ed on Market WatchLeonard Fleck, PhD, professor in the Center for Bioethics and Social Justice, writes about the FDA's approval of a new Alzheimer’s Drug. Related News: MSU Bioethics.
  • Tune into the latest episodes of "Get to Know," a podcast hosted by Andrew Kim highlighting the stories of fellow MSU College of Human Medicine students: The Scenic Route | Bridget Gongol, Why Not Both? | Mitchell Doerr and Healthcare IT | Kyle Bivins.